Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
241.67
+4.34 (1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
246.64
+4.97 (2.06%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Axsome Therapeutics stock have an average target of 264.53, with a low estimate of 200 and a high estimate of 310. The average target predicts an increase of 9.46% from the current stock price of 241.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Axsome Therapeutics stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 17 | 17 | 17 | 17 | 17 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $258 | Buy | Reiterates | $258 | +6.76% | Jun 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $275 → $300 | Buy | Maintains | $275 → $300 | +24.14% | Jun 17, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $255 | Buy | Maintains | $255 | +5.52% | Jun 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $310 | Buy | Reiterates | $310 | +28.27% | Jun 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $290 | Buy | Reiterates | $290 | +20.00% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
985.26M
from 638.50M
Increased by 54.31%
Revenue Next Year
1.60B
from 985.26M
Increased by 62.14%
EPS This Year
-1.75
from -3.47
EPS Next Year
5.90
from -1.75
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | 2.0B | |
| Avg | 985.3M | 1.6B | |
| Low | 867.6M | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 75.3% | 104.0% | |
| Avg | 54.3% | 62.1% | |
| Low | 35.9% | 41.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.30 | 12.53 | |
| Avg | -1.75 | 5.90 | |
| Low | -3.35 | 1.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.